ARHGAP32 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.080960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.230760E-01
Normal-vs-Stage2
9.139500E-02
Normal-vs-Stage3
3.404000E-01
Normal-vs-Stage4
1.556830E-01
Stage1-vs-Stage2
7.494400E-01
Stage1-vs-Stage3
6.696800E-01
Stage1-vs-Stage4
5.081600E-01
Stage2-vs-Stage3
4.653600E-01
Stage2-vs-Stage4
5.465200E-01
Stage3-vs-Stage4
4.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.191610E-01
Normal-vs-AfricanAmerican
8.452100E-02
Normal-vs-Asian
1.762440E-01
Caucasian-vs-AfricanAmerican
6.329400E-01
Caucasian-vs-Asian
9.370200E-01
AfricanAmerican-vs-Asian
6.588400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.120390E-01
Normal-vs-Female
1.090430E-01
Male-vs-Female
2.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.599000E-01
Normal-vs-Age(41-60Yrs)
8.937600E-02
Normal-vs-Age(61-80Yrs)
1.220020E-01
Normal-vs-Age(81-100Yrs)
1.538760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.833400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.252400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.999000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.113620E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.649200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.870000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.500500E-02
Normal-vs-Daily Drinker
2.342400E-01
Normal-vs-Weekly Drinker
2.385600E-01
Normal-vs-Occasional Drinker
9.630000E-02
Normal-vs-Social Drinker
4.218000E-02
Non Drinker-vs-Daily Drinker
6.293800E-01
Non Drinker-vs-Weekly Drinker
4.257200E-01
Non Drinker-vs-Occasional Drinker
4.037200E-01
Non Drinker-vs-Social Drinker
4.207000E-01
Daily Drinker-vs-Weekly Drinker
7.773200E-01
Daily Drinker-vs-Occasional Drinker
2.849800E-01
Daily Drinker-vs-Social Drinker
8.033200E-01
Weekly Drinker-vs-Occasional Drinker
2.061200E-01
Weekly Drinker-vs-Social Drinker
9.093400E-01
Occasional Drinker-vs-Social Drinker
1.453820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.043230E-01
Normal-vs-Grade 2
2.278000E-02
Normal-vs-Grade 3
1.228100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.760300E-02
Grade 1-vs-Grade 3
2.357100E-03
Grade 1-vs-Grade 4
1.043230E-01
Grade 2-vs-Grade 3
1.243780E-01
Grade 2-vs-Grade 4
2.278000E-02
Grade 3-vs-Grade 4
1.228100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.796800E-01
Normal-vs-NonDiabetic
1.024000E-01
Diabetic-vs-NonDiabetic
1.050780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.627600E-02
Normal-vs-NoPancreatitis
1.333840E-01
Pancreatitis-vs-NoPancreatitis
3.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.554000E-02
Normal-vs-N1
1.040210E-01
N0-vs-N1
9.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.124410E-02
Normal-vs-TP53-NonMutant
1.933400E-01
TP53-Mutant-vs-TP53-NonMutant
6.170700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
